Results 151 to 160 of about 605,611 (288)
Glymphatic Dysfunction in Children With Type 2 and 3 Spinal Muscular Atrophy. [PDF]
Lan S +10 more
europepmc +1 more source
Absence seizures: Update on signaling mechanisms and networks
Abstract Absence seizures (AS) are a hallmark of genetic generalized epilepsies (GGE), characterized by brief episodes of impaired consciousness accompanied by electroencephalographic spike‐and‐wave discharges (SWDs). Traditionally attributed to cortico‐thalamo‐cortical (CTC) dysrhythmia, emerging evidence suggests a more intricate pathophysiological ...
Ozlem Akman, Filiz Onat
wiley +1 more source
Abnormal auditory neural activity in individuals with spinal muscular atrophy. [PDF]
Rance G, Yiu EM.
europepmc +1 more source
Abstract Background Dexmedetomidine infusions are beneficial in anaesthetised endotoxaemic horses when administered concurrent to endotoxin, but post‐conditioning effects are unknown. Objectives To evaluate whether a dexmedetomidine infusion is beneficial in horses administered Escherichia coli O55:B5 lipopolysaccharides (LPS) endotoxin prior to ...
Sera Lee +4 more
wiley +1 more source
Access to care for adults living with spinal muscular atrophy in the UK. [PDF]
Muni-Lofra R +40 more
europepmc +1 more source
Similar locomotor patterns across Quarter Horse disciplines inform lameness assessment
Abstract Background Lineage‐based selection is central to the Quarter Horse industry and is often justified by the assumption that morphology determines locomotor function. However, objective evidence linking static conformation to discipline‐specific locomotor behaviour under standardised conditions remains limited.
Renata Farinelli de Siqueira +4 more
wiley +1 more source
Cognitive and neurodevelopmental outcomes in spinal muscular atrophy: a scoping review. [PDF]
Gnazzo M +8 more
europepmc +1 more source
This review highlights recent advances in engineering messenger RNA (mRNA)‐lipid nanoparticles (LNPs) to cross the ageing blood–brain barrier and target neurodegenerative diseases. It outlines design principles, delivery routes, and translational challenges, charting a roadmap towards clinical application of mRNA‐LNP therapeutics for neurodegenerative ...
Abdel Ali Belaidi +5 more
wiley +1 more source
Spinal muscular atrophy in the disease-modifying therapy era: successes, limitations and future directions. [PDF]
Sexton MM, Crow EW, Peng CA.
europepmc +1 more source
Wearable Robot Boosts Muscle Recovery in Adolescents With Spinal Muscular Atrophy
Isokinetic training robot with a variable stiffness mechanism for juveniles with SMA type II. Credit: Yuebing Li et al./Nature. ABSTRACT Yuebing Li and colleagues developed a lightweight wearable device integrating a variable‐stiffness mechanism with a back‐drivable damping motor to deliver isokinetic resistance training for adolescents with spinal ...
Yin Huang
wiley +1 more source

